Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Rosso Pharmaceutical is a professional pharmaceutical company founded in 2006 and based in Shenzhen, China. It operates primarily as a Contract Sales Organization specializing in the import and distribution of pharmaceutical products within the Chinese market. The company has established strong relationships with several overseas manufacturers and provides regulatory affairs services to facilitate drug registration and licensing in China. Its sales network covers all of mainland China, supported by over 280 full-time sales representatives. The company is involved both in commercializing imported drugs and conducting clinical research; notably, it sponsored a multicenter Phase 3 trial evaluating intravitreal triamcinolone acetonide for vitreous visualization during eye surgery. Products handled include Kamistad gel, Uralyt-U, Legalon, Miyari, Min Tong, Colphos among others.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Rosso Pharmaceutical.